5 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
ASCVD or ASCVD risk ... in HFrEF on GDMT ... outcomes in HFrEF ... SGLT2 #inhibitors #EBM ... #table #CVD #CKD
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
ejection fraction; GDMT ... HFpEF, heart failure ... ejection fraction; HFrEF ... #CHF #Congestive ... #Management #Cardiology
Iron Deficiency in Heart Failure - Diagnosis and Treatment Algorithm
Diagnosis: Ferritin <100 ng/mL (absolute ID) OR
in Heart Failure ... Guidelines: • ACC ... patients with HFrEF ... #HFrEF #heartfailure ... #diagnosis #management
Iron Deficiency in Heart Failure
Pathophysiology:
Chronic heart failure leads to an increase in inflammatory cytokines → Inflammation
showed reduced risk ... mortality and CV ... #deficiency #CHF ... #HFrEF #heartfailure ... #diagnosis #management
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
disease b) CHF ... algorithm to determine ... CARP, DECREASE V trials ... medical and surgical management ... stratification #diagnosis